Bacterial Epidural Abscess with Pyogenic and Tuberculous Spondylodiscitis Coinfection: Literature for Case Report
For a case report on concomitant bacterial epidural abscess with pyogenic and tuberculous spondylodiscitis, the most relevant recent literature includes case reports from 2023-2026 documenting this rare dual-pathogen presentation, alongside foundational guidelines from IDSA (2015) and ACR (2021) that establish diagnostic and management frameworks.
Key Literature for Your Case Report
Recent Case Reports of Dual Infection
The most directly relevant case report is the 2023 publication by 1, which describes a mixed pyogenic and tuberculous spinal epidural abscess that perforated the dura and extended into the subdural space in a 29-year-old male with IV drug use history. This case demonstrates the clinical presentation (progressive back pain, lower-limb weakness, radicular pain, incontinence, low-grade fever, night sweats) and successful management with emergent laminectomy, culture-directed antibiotics, and anti-TB therapy.
A 2019 case report 2 documents concurrent spinal epidural tubercular and pyogenic abscess of the cervical spine without bony involvement—an unusual presentation that emphasizes the importance of sending pus for both bacterial and mycobacterial culture even when osseous changes are absent.
The 2025 pediatric case 3 presents concomitant pyogenic atlantoaxial spondylodiscitis with retropharyngeal abscesses alongside tuberculous spondylodiscitis with gibbus deformity, demonstrating multilevel dual infection requiring staged surgical intervention.
Historical Foundation Case
The seminal 2003 case report 4 established critical diagnostic principles: isolation of pyogenic bacteria does not exclude tuberculosis. This case showed Nocardia asteroids, Moraxella catarrhalis, and Mycobacterium tuberculosis from the same lumbar spine infection. The authors identified key clinical clues: chronic infection unresponsive to standard antibiotics, low-virulence pyogenic organisms, psoas muscle calcification, and immunosuppression.
Diagnostic Framework from Guidelines
IDSA 2015 Guidelines 5
For suspected treatment failure or atypical presentations, the IDSA strongly recommends:
- Obtaining tissue samples for bacterial, fungal, AND mycobacterial cultures (not just routine bacterial cultures)
- Image-guided aspiration biopsy or surgical sampling when clinical and radiographic evidence suggests treatment failure
- Consultation with spine surgery and infectious disease specialists
ACR 2021 Appropriateness Criteria 6
The ACR guidelines emphasize:
- MRI as the gold standard for suspected spine infection, including epidural abscess and spondylodiscitis
- Testing for mycobacterium when patients are from endemic areas or have appropriate risk factors
- Spine biopsy with microbiologic and histopathologic analysis is often required because imaging appearance overlaps between pyogenic and tuberculous infection
- Specific pathogens like tuberculosis may demonstrate multilevel spine involvement 6
- Epidural abscess incidence is 2.5-3/10,000 patients and carries significant morbidity/mortality risk with diagnostic delay 6
Comparative Clinical Series
Large Comparative Studies
The 1994 study 7 of 80 adult patients with spondylodiskitis found tuberculosis in 39% and pyogenic bacteria in 61%. Key differentiating features: tuberculous cases more commonly came from endemic countries (55%, P<0.001), had previous TB infection (42%), and showed neurological complications (32%). Blood cultures were positive in 56% of pyogenic cases but only contributed to diagnosis in 3% of tuberculous cases.
The 2026 retrospective analysis 8 of 114 cases provides modern comparative data: tuberculous spondylodiscitis showed longer symptom duration, night sweats, thoracic involvement, and abscess formation more frequently than pyogenic cases. Leucocytosis was significant in pyogenic cases.
Imaging Differentiation
The 2026 narrative review 9 synthesizes imaging evidence for TS versus PS differentiation:
- Features favoring tuberculosis: thoracic predominance, multilevel/non-contiguous involvement, early disc preservation, subligamentous spread, intraosseous abscesses, thin-walled paravertebral collections, severe vertebral collapse with kyphosis
- Features favoring pyogenic: lumbar predominance, early disc-endplate destruction, homogeneous inflammatory enhancement, facet-joint arthritis, epidural phlegmon
Critical Clinical Pearls for Your Case Report
Risk Factors for Dual Infection 1, 4
Multiple risk factors increase dual-pathogen likelihood:
- IV drug abuse
- Immunosuppression (HIV, diabetes, steroids)
- Recent TB contact
- Unprotected sexual contact
- Geographic origin from TB-endemic areas
Diagnostic Pitfalls to Highlight
The most critical pitfall: assuming a single pathogen when pyogenic bacteria are isolated first 4. Your case report should emphasize:
- Always send tissue for mycobacterial culture, even when pyogenic organisms are recovered
- Chronic infection unresponsive to appropriate antibiotics should trigger mycobacterial investigation
- Low-virulence pyogenic organisms (Nocardia, Moraxella, Corynebacterium) may coexist with TB 4
- Psoas muscle calcification on plain radiographs suggests tuberculous involvement 4
Management Principles
The 2026 comprehensive review 10 outlines that bacterial spondylodiscitis requires:
- Prolonged antibiotic therapy even with surgical intervention
- Antimicrobial susceptibility testing when organisms are identified
- Empirical therapy when causative agents cannot be identified
- Surgical intervention for spinal instability, neurological deficits, or failed medical management
Structure Your Case Report Around These Elements
Clinical presentation emphasizing dual-infection risk factors and atypical features (chronic course despite antibiotics, mixed inflammatory markers)
Imaging findings documenting features of both pyogenic and tuberculous infection on MRI/CT 9
Microbiological confirmation showing both pyogenic and mycobacterial organisms from the same tissue sample—this is the case report's key contribution 1, 2, 4
Treatment approach combining surgical decompression, culture-directed antibiotics, and anti-TB therapy 1, 3
Clinical outcome demonstrating the importance of recognizing dual infection for successful management
Discussion citing the rarity (only handful of published cases), diagnostic challenges, and the critical teaching point that pyogenic isolation does not exclude tuberculosis 4
The evidence base for this entity remains limited to case reports and small series, making your case report a valuable addition to the literature. The 2023 case 1 and the foundational 2003 case 4 should be your primary references for framing the discussion of dual infection.